← Open Payments lookup

ALEXANDRIA GLENDENNING: Open Payments

NPI 1629619937 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,070 in 78 payments from 15 companies in 2025. Trend: 2023 $1,416 · 2024 $1,070 · 2025 $1,070

Food & beverage: $1,070
CompanyPaymentsAmount
ABBVIE INC.29$199
Novo Nordisk Inc12$194
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$173
Lilly USA, LLC7$120
Axsome Therapeutics, Inc.3$62
PFIZER INC.3$57
Bayer Healthcare Pharmaceuticals Inc.3$52
Gilead Sciences, Inc.2$52
Corcept Therapeutics2$45
AstraZeneca Pharmaceuticals LP2$36

Products named: CAPLYTA, MOUNJARO, Wegovy, VRAYLAR, Ozempic, Auvelity, Kerendia, QULIPTA.

Industry payments across OK — which companies pay providers there.